EXAGEN INC. Gain (Loss) on Disposition of Assets
EXAGEN INC. (XGN) reported Gain (Loss) on Disposition of Assets of -$6.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-05-05
- EXAGEN INC. gain (loss) on disposition of assets for the quarter ending 2025-03-31 was -$6.00K.
- EXAGEN INC. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- EXAGEN INC. gain (loss) on disposition of assets for the quarter ending 2024-06-30 was -$75.00K.
- EXAGEN INC. gain (loss) on disposition of assets for fiscal 2024 was -$111.00K.
- EXAGEN INC. gain (loss) on disposition of assets for fiscal 2023 was -$189.00K.
- EXAGEN INC. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
- EXAGEN INC. gain (loss) on disposition of assets for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$6.00K 10-Q · filed 2025-05-05 | -$6.00K derived: sum of 2 quarters · filed 2025-05-05 | -$6.00K derived: sum of 3 quarters · filed 2025-05-05 | -$81.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | -$75.00K derived: sum of 3 quarters · filed 2025-03-11 | -$111.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$75.00K derived: sum of 2 quarters · filed 2024-11-12 | -$111.00K 10-Q · filed 2024-11-12 | -$91.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$111.00K 10-Q · filed 2024-08-05 | -$91.00K derived: sum of 3 quarters · filed 2025-05-05 | -$171.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-03-31 | -$36.00K 10-Q · filed 2025-05-05 | -$16.00K derived: sum of 2 quarters · filed 2025-05-05 | -$96.00K derived: sum of 3 quarters · filed 2025-05-05 | -$170.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$60.00K derived: sum of 2 quarters · filed 2025-03-11 | -$134.00K derived: sum of 3 quarters · filed 2025-03-11 | -$189.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$154.00K derived: sum of 2 quarters · filed 2024-11-12 | -$209.00K 10-Q · filed 2024-11-12 | -$209.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$129.00K 10-Q · filed 2024-08-05 | -$129.00K derived: sum of 3 quarters · filed 2024-08-05 | -$129.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$55.00K 10-Q · filed 2024-05-13 | -$55.00K derived: sum of 2 quarters · filed 2024-05-13 | -$55.00K derived: sum of 3 quarters · filed 2024-05-13 | -$55.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 derived: sum of 3 quarters · filed 2024-03-18 | $0.00 10-K · filed 2024-03-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $0.00 10-Q · filed 2020-07-28 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $197.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $197.00K derived: sum of 3 quarters · filed 2021-03-16 | -$16.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $197.00K derived: sum of 2 quarters · filed 2021-03-16 | -$16.00K derived: sum of 3 quarters · filed 2021-03-16 | -$20.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$16.00K derived: sum of 2 quarters · filed 2020-11-10 | -$20.00K 10-Q · filed 2020-11-10 | -$26.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$217.00K 10-Q · filed 2020-07-28 | -$223.00K derived: sum of 3 quarters · filed 2020-07-28 | |
| 2019-03-31 | -$4.00K 10-Q · filed 2020-05-11 | -$10.00K derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$6.00K 10-K · filed 2020-03-25 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |